Candidate gene studies have revealed limited genetic bases for opioid analgesic response variability. Genome-wide association studies facilitate impartial queries of common genetic variants, allowing identification of novel genetic contributions to drug effect. Illumina (Illumina Inc, San Diego, CA, USA) single nucleotide polymorphism (SNP) arrays were used to investigate SNP associations with total morphine requirement as a quantitative trait locus and with postoperative pain in a retrospective population of opioid-naïve children ages 4-18 years who had undergone day surgery tonsillectomy and adenoidectomy. In an independent replication cohort, significant genome-wide association studies-identified SNPs were assayed using TaqMan probes. Among 617 comprehensively phenotyped children, the 277 subjects of European Caucasian (EC) ancestry demonstrated nominal association between morphine dose and a series of novel SNPs (top rs795484, P = 1.01 Â 10 À6 and rs1277441, P = 2.77 Â 10
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) at the TAOK3 locus. Age, body mass index, and physical status were included covariates. Morphine requirement averaged 132.4 lg/kg (SD 40.9) . Each minor allele at rs795484 (guanine [G] > adenine [A]) contributed +17.6 lg/kg (95% confidence interval [CI] 10.7-24.4) to dose. Effect direction and magnitude were replicated in an independent cohort of 75 EC children (P < 0.05). No association with morphine dose was detected in African Americans (AA) (n = 241). Postoperative pain scores P7/10 were associated with rs795484 (G > A) in the EC cohort (odds ratio 2.35, 95% CI 1.56-3.52, P < 0.00005) and this association replicated in AA children (odds ratio 1.76, 95% CI 1.14-2.71, P < 0.01). Variants in TAOK3 encoding the serine/ threonine-protein kinase, TAO3, are associated with increased morphine requirement in children of EC ancestry and with increased acute postoperative pain in both EC and AA subjects.
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Introduction
Despite its extensive history as an effective postoperative analgesic [21] , morphine sulfate exhibits inconsistent relationships between dosage and analgesic efficacy in both adults [3, 4] and children [19, 30, 31] . Indeed, clinical response variability to morphine may be greater than that seen with other opioids [10] . Genetic and environmental factors contribute to interindividual variability on multiple levels, from pain processing and perception to specific alterations in opioid pharmacokinetics and pharmacodynamics, and interactions among all factors are highly complex [14, 35, 41, 60, 62] . Genetic research on opioid analgesic response has focused on select single nucleotide polymorphisms (SNPs) in candidate genes encoding proteins associated with known opioid pharmacokinetics and pharmacodynamics and those associated with alternate pain-related pathways [32, 40, 46] 
